NCT00402389View on ClinicalTrials.gov

Use of Omega-3 Fatty Acids for Perinatal Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
DepressionDepression, Postpartum
Interventions
DRUG

Omega-3 Fatty Acids (EPA plus DHA)

Four capsules will be taken daily for 8 weeks.

BEHAVIORAL

Supportive psychotherapy

Supportive psychotherapy will provide education to increase understanding of the condition, guidance on how to cope with depression, and methods on how to improve self-esteem.

DRUG

Placebo

Four capsules will be taken daily for 8 weeks.

Trial Locations (1)

85724

Women's Mental Health Program; University of Arizona; Department of Psychiatry, Tucson

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Arizona

OTHER

NCT00402389 - Use of Omega-3 Fatty Acids for Perinatal Depression | Biotech Hunter | Biotech Hunter